SCHEMBL7913345

SCHEMBL7913345

CCC(CC)C(O)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.60
AOC3 Q16853 4/20 0.55
ADRA2C P18825 2/20 0.52
KDM4E B2RXH2 2/20 0.52
ADRA2A P08913 1/20 0.52
HIF1A Q16665 1/20 0.52
ALDH1A1 P00352 2/20 0.50
SLC6A2 P23975 4/20 0.49
SLC6A4 P31645 4/20 0.49
SLC6A3 Q01959 4/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2D6 P10635 2/20 0.49
KCNH2 Q12809 1/20 0.49
CHRM2 P08172 1/20 0.48
ADRA1A P35348 1/20 0.48
RGS12 O14924 1/20 0.48
GLA P06280 1/20 0.48
CYP2C9 P11712 1/20 0.48
PKM P14618 1/20 0.48
ALOX15 P16050 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11077174 0.89 LMNA (0.54) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL8037032 0.87 LMNA (0.52) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL7914382 0.87 AOC3 (0.58) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL13122615 0.84 ALDH1A1 (0.50) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL21536764 0.84 LMNA (0.48) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL18087746 0.81 LMNA (0.60) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL6939841 0.81 LMNA (0.60) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL9480262 0.79 SLC6A2 (0.61) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL14388207 0.79 AOC3 (0.58) LMNAAOC3ADRA2CKDM4EADRA2A
SCHEMBL10255083 0.79 AOC3 (0.58) LMNAAOC3ADRA2CKDM4EADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017048796-A1 GAMMA IRRADIATION OF ION EXCHANGE RESINS TO REMOVE HALOGENATED IMPURITIES EVOQUA WATER TECHNOLOGIES LLC (US) 2017-03-23 WO disclosed
EP-2520570-A1 AMINOPYRIDINE COMPOUND Ube Industries, Ltd. (JP) 2012-11-07 EP disclosed
US-20120259123-A1 AMINOPYRIDINE COMPOUND UBE INDUSTRIES, LTD. (JP) 2012-10-11 US disclosed
US-6207739-B1 Polyamide acid composition containing metal, polyimide film, flexible printed wiring board and method for producing them KANEGAFUCHI KAGAKU KOGYO KABUSHIKI (JP) 2001-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120259123-A1 AMINOPYRIDINE COMPOUND PTGIS, QDPR, PTGIR LMNA 2495/4885AOC3 2626/4885ADRA2C 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.